Mitsui Chemicals completed its $900 million acquisition of South Jordan-based Ultradent Products on Aug. 14, 2026, several weeks before the originally announced September closing timetable, according to a Sept. 16 report. The deal marks the beginning of a strategic move to transform South Jordan into a global management hub for the company's oral-care operations.
Effective Oct. 1, 2026, the newly formed MC Dental Holdings America, based in South Jordan, will oversee and manage Mitsui Chemicals' entire oral-care business. This new management structure will include Ultradent, Germany-based Kulzer Group, and Japan-based Sun Medical. To facilitate this, Mitsui Chemicals will abolish its existing Oral Care Business Division in Japan and transfer those business-management functions to the Utah-based entity.
The restructuring involves significant leadership changes and operational shifts. Ultradent President and CEO Dirk Jeffs is slated to serve concurrently as CEO of Kulzer, while Kulzer's current CEO, Chris Holden, will move into the role of Chief Strategy and Integration Officer at MC Dental Holdings America. Additionally, Mitsui Chemicals executive Shingo Ono will relocate to the United States to serve as president of the South Jordan-based company.
Mitsui Chemicals aims to realize over $40 million in annual synergistic benefits by fiscal 2030 through integration initiatives such as cross-selling and product development. The company's ultimate objective for this consolidation is to become the number two leader in the global oral-care marketplace. While management moves to Utah, Sun Medical will remain in Moriyama, Shiga Prefecture, Japan, where it will act as a core operating and technology platform for the company's dental 3D-printing business.
The $900 million transaction for Ultradent represents approximately 2.4 times its 2025 revenue. During 2025, Ultradent reported $372.1 million in consolidated sales, $30.9 million in operating income, and $24.0 million in net income. The acquisition was completed following required competition-law and foreign-investment approvals and notifications.
The expansion of the South Jordan operations follows Mitsui Chemicals' initial disclosure of its intent to acquire Ultradent in mid-June 2026.
